Back to Search
Start Over
Features of neovascularization in pachychoroid neovasculopathy compared with type 1 neovascular age-related macular degeneration on optical coherence tomography angiography
- Source :
- Japanese Journal of Ophthalmology. 64:257-264
- Publication Year :
- 2020
- Publisher :
- Springer Science and Business Media LLC, 2020.
-
Abstract
- To compare neovascular membrane features of pachychoroid neovasculopathy (PNV) and type 1 neovascular age-related macular degeneration (nAMD) using optical coherence tomography angiography (OCTA). Retrospective study. We assessed 34 treatment-naive eyes with a diagnosis of PNV and 36 treatment-naive eyes with a diagnosis of type 1 nAMD. Morphological patterns of neovascular membranes were categorized, and lesion sizes and flow areas were calculated by using en face images on the AngioVue (Optovue) OCTA system. Statistically significant differences were found between groups in age (P=0.001), baseline best corrected visual acuity (P=0.005), and baseline subfoveal choroidal thickness (P
- Subjects :
- Indocyanine Green
Male
medicine.medical_specialty
genetic structures
Indocyanine green angiography
Visual Acuity
Ciliary Arteries
Lesion
Neovascularization
03 medical and health sciences
0302 clinical medicine
Age related
Ophthalmology
medicine
Humans
Fluorescein Angiography
Coloring Agents
Aged
Retrospective Studies
Aged, 80 and over
medicine.diagnostic_test
Choroid
business.industry
Flow area
General Medicine
Optical coherence tomography angiography
Macular degeneration
medicine.disease
Choroidal Neovascularization
eye diseases
Angiography
Wet Macular Degeneration
030221 ophthalmology & optometry
Female
sense organs
medicine.symptom
business
Tomography, Optical Coherence
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 16132246 and 00215155
- Volume :
- 64
- Database :
- OpenAIRE
- Journal :
- Japanese Journal of Ophthalmology
- Accession number :
- edsair.doi.dedup.....6d883f08127fa8a0da7d81ba36051109
- Full Text :
- https://doi.org/10.1007/s10384-020-00730-7